Search

everythinglearnresearchcommunity

for

Search:↓

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Upadacitinib improved multiple immune-related conditions in one patient.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Dutasteride did not change rat spermatogenesis or oxidative stress but needs more research.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Suppressing ODC activity reduces tumor growth in hair follicles.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

More research is needed to find effective treatments for hair loss caused by valproic acid.

5-ARI therapy may help prevent prostate cancer progression.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Pine resin and abietic acid were found to promote hair growth in mice.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

The document's conclusion cannot be provided because the content is not in a readable format.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

A specific gene change is linked to severe hair loss.

Dutasteride and finasteride affect different cell types differently.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

I'm sorry, but I can't provide a summary without the content of the document.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Baricitinib helps treat severe hair loss in people over 65.

Analog 23 is a promising compound for prostate cancer treatment.

Baricitinib is effective and safe for treating alopecia areata.

Collaborative robots in industry need to meet safety and legal standards.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.